LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2018/1122 of 10 August 2018 authorising the placing on the market of pyrroloquinoline quinone disodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2018/1122 of 10 August 2018 authorising the placing on the market of pyrroloquinoline quinone disodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance.)

Implementing Regulation (EU) 2018/1122 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   Pyrroloquinoline quinone disodium salt as specified in the Annex to this Regulation shall be included in the Union list of authorised novel foods established in Implementing Regulation (EU) 2017/2470. 2.   For a period of five years from the date of entry into force of this Regulation only the initial Applicant:   Company: Mitsubishi Gas Chemical Company, Inc.   Address: Mitsubishi Building 5-2 Marunouchi 2-chome, Chiyoda-ku, Tokyo 100-8324, Japan is authorised to place on the market within the Union the novel food referred to in paragraph 1, unless a subsequent applicant obtains authorisation for the novel food without reference to the data protected pursuant to Article 2 of this Regulation or with the agreement of Mitsubishi Gas Chemical Company, Inc. 3.   The entry in the Union list referred to in the first paragraph shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation. 4.   The authorisation provided for in this Article shall be without prejudice to the provisions of Directive 2002/46/EC.

Article 2

Open ↗

The studies contained in the application file on the basis of which the novel food referred to in Article 1 has been assessed by the Authority, claimed by the applicant as proprietary and without which the data protection could not have been authorised, shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of Mitsubishi Gas Chemical Company, Inc.

Article 3

Open ↗

The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 4

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) the following last column is added in Table 1 (Authorised novel foods): ‘Data Protection’ (2) The following entry is inserted in Table 1 (Authorised novel foods) in alphabetical order: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data Protection ‘ Pyrroloquinoline quinone disodium salt Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be “Pyrroloquinoline quinone disodium salt”. Food supplements containing Pyrroloquinoline quinone disodium salt shall bear the following statement: This food supplement should be consumed by adults only excluding pregnant and lactating women   Authorised on 2 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Mitsubishi Gas Chemical Company, Inc., Mitsubishi Building 5-2 Marunouchi 2-chome, Chiyoda-ku, Tokyo 100-8324, Japan. During the period of data protection the novel food Pyrroloquinoline quinone disodium salt is authorised for placing on the market within the Union only by Mitsubishi Gas Chemical Company, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Mitsubishi Gas Chemical Company, Inc. End date of the data protection: 2 september 2023’ Food Supplements as defined in Directive 2002/46/EC intended for the adult population, excluding pregnant and lactating women 20 mg/day (3) The following entry is inserted in Table 2 (Specifications) in alphabetical order: Authorised Novel Food Specification ‘ Pyrroloquinoline quinone disodium salt Definition: Chemical name: disodium 9-carboxy-4,5-dioxo-1 H -pyrrolo[5,4-f]quinoline-2,7-dicarboxylate Chemical formula: C 14 H 4 N 2 Na 2 O 8 CAS No: 122628-50-6 Molecular weight: 374,17 Da Description Pyrroloquinoline quinone disodium salt is a reddish–brown powder produced by the non-genetically modified bacterium Hyphomicrobium denitrificans strain CK-275. Characteristics/Composition Appearance: Reddish-brown powder Purity: ≥ 99,0 % (dry weight) UV absorbance (A322/A259): 0,56 ± 0,03 UV absorbance (A233/A259): 0,90 ± 0,09 Moisture: ≤ 12,0 % Residual Solvent Ethanol: ≤ 0,05 % Heavy metals Lead: < 3 mg/kg Arsenic: < 2 mg/kg Microbiological criteria: Total viable cell count: ≤ 300 CFU/g Mould/yeast: ≤ 12 CFU/g Coliforms: absent in 1 g Hyphomicrobium denitrificans : ≤ 25 CFU/g CFU: Colony Forming Units’

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1527 of 29 July 2025 concerning the authorisation of a preparation of Lactiplantibacillus plantarum NCIMB 41028 and a preparation of Lactiplantibacillus plantarum NCIMB 30148 as feed additives for all animal speciesCommission Delegated Regulation (EU) 2025/1535 of 29 July 2025 supplementing Regulation (EU) 2024/2847 of the European Parliament and of the Council with regard to an exclusion from the application of that Regulation for certain products with digital elements falling within the scope of Regulation (EU) No 168/2013 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1536 of 29 July 2025 setting out the procedure concerning the mobilisation of the enhanced emergency capacity of the EU Health Task ForceCommission Implementing Regulation (EU) 2025/1537 of 29 July 2025 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21 (DE3)Commission Implementing Regulation (EU) 2025/1566 of 29 July 2025 laying down rules for the application of Regulation (EU) No 910/2014 of the European Parliament and of the Council as regards reference standards for the verification of the identity and attributes of the person to whom the qualified certificate or the qualified electronic attestation of attributes is to be issuedCommission Implementing Regulation (EU) 2025/1567 of 29 July 2025 laying down rules for the application of Regulation (EU) No 910/2014 of the European Parliament and of the Council as regards the management of remote qualified electronic signature creation devices and of remote qualified electronic seal creation devices as qualified trust servicesCommission Implementing Regulation (EU) 2025/1568 of 29 July 2025 laying down rules for the application of Regulation (EU) No 910/2014 of the European Parliament and of the Council as regards procedural arrangements for peer reviews of electronic identification schemes and for cooperation on the organisation of such reviews within the Cooperation Group and repealing Commission Implementing Decision (EU) 2015/296Commission Implementing Regulation (EU) 2025/1569 of 29 July 2025 laying down rules for the application of Regulation (EU) No 910/2014 of the European Parliament and of the Council as regards qualified electronic attestations of attributes and electronic attestations of attributes provided by or on behalf of a public sector body responsible for an authentic sourceCommission Implementing Regulation (EU) 2025/1570 of 29 July 2025 laying down rules for the application of Regulation (EU) No 910/2014 of the European Parliament and of the Council as regards notification of information on certified qualified electronic signature creation devices and certified qualified electronic seal creation devicesCommission Implementing Regulation (EU) 2025/1571 of 29 July 2025 laying down rules for the application of Regulation (EU) No 910/2014 of the European Parliament and of the Council as regards the formats and procedures for annual reports by supervisory bodiesCommission Implementing Regulation (EU) 2025/1572 of 29 July 2025 laying down rules for the application of Regulation (EU) No 910/2014 of the European Parliament and of the Council as regards the format and procedures for notification of intention and verification with regard to the initiation of qualified trust servicesCouncil Implementing Regulation (EU) 2025/1576 of 29 July 2025 implementing Regulation (EU) 2022/2309 concerning restrictive measures in view of the situation in Haiti

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next